Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial by MacLaren, RE, Fischer, MD, Gow, JA, Lam, BL, Sankila, E-MK, Girach, A, Panda, S, Yoon, D, Zhao, G, Pennesi, ME

Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR by Cehajic-Kapetanovic, J, Xue, K, Martinez-Fernandez de la Camara, C, Nanda, A, Davies, A, Wood, LJ, Salvetti, AP, Fischer, MD, Aylward, JW, Barnard, AR, Jolly, JK, Luo, E, Lujan, BJ, Ong, T, Girach, A, Black, GCM, Gregori, NZ, Davis, JL, Rosa, PR, Lotery, AJ, Lam, BL, Stanga, PE, MacLaren, RE